Gene Editing Market Size , Industry, Share, Analysis, Trends and Global Forecast 2025 - 2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	250 Pages	Acumen Research and Consulting	March, 2025	ACRC19838265

Best Price Guarantee
Price	from $4,500
Length	250 Pages
Publisher	Acumen Research and Consulting
Published Date	March, 2025
SKU	ACRC19838265

The Global Gene Editing Market Size accounted for USD 18.3 Billion in 2024 and is estimated to achieve a market size of USD 73.7 Billion by 2033 growing at a CAGR of 16.9% from 2025 to 2033.

The gene editing market has experienced transformative growth in recent years, driven by groundbreaking advancements in molecular biology, biotechnology, and genomics. Gene editing refers to the process of making precise alterations to an organism’s DNA, enabling the targeted modification of genetic material to treat diseases, enhance agricultural productivity, and create genetically modified organisms (GMOs). The market for gene editing technologies, especially CRISPR-Cas9, TALENs, and ZFNs, has expanded dramatically due to their ability to offer significant advantages over traditional genetic modification methods, such as faster results, higher accuracy, and lower costs. As a result, the gene editing market has witnessed wide applications in medicine, agriculture, and industrial biotechnology, with the potential to revolutionize various fields by offering solutions to genetic disorders, improving food security, and advancing personalized medicine.

Gene Editing Market Segmentation

The worldwide market for gene editing is split based on technology, product & services, application, end-user, and geography.

Gene Editing Market By Technology

CRISPR
TALEN
ZFN
Other Technologies

Gene Editing Market By Product & Services

Reagents & Consumables
Software & Systems
Services

Gene Editing Application

Cell Line Editing
Animal Genome Editing
Plant Genome Editing
Other

Gene Editing End-user

Pharmaceutical & Biotechnology Companies
Academics And Government Research Institutes
Clinical Research Organizations (CRO)

Gene Editing Market Regional Outlook

North America

U.S.

Canada

Europe

U.K.
Germany
France
Spain

Rest of Europe

Asia-Pacific

India
Japan
China
Australia
South Korea

Rest of Asia-Pacific

Latin America

Brazil
Mexico

Rest of LATAM

The Middle East & Africa

South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

Gene Editing Market Players

Some of the top gene editing companies offered in our report include Sangamo Biosciences, Addgene, Thermo Fisher Scientific, Horizon Discovery Group plc, Allele Biotech, Bio-Rad, Caribou Biosciences, Inc., Precision Biosciences, CRISPR Therapeutics, GE Healthcare, GeneCopoeia, Inc., Integrated DNA Technologies, GenScript Corporation, and OriGene Technologies.

CHAPTER 1 Industry Overview of Gene Editing Market: 1.1 Definition and Scope; 1.2 Summary
CHAPTER 2 Research Approach: 2.1 Methodology; 2.2 Data Source
CHAPTER 3 Market Dynamics And Competition Analysis: 3.1 Market Drivers; 3.2 Restraints and Challenges; 3.3 Growth Opportunities; 3.4 Porter’s Five Forces Analysis; 3.5 Market Concentration Ratio and Market Maturity Analysis of Gene Editing Market; 3.5.1 Go To Market Strategy; 3.5.1.1 Introduction; 3.5.1.2 Growth; 3.5.1.3 Maturity; 3.5.1.4 Saturation; 3.5.1.5 Possible Development; 3.6 Technological Roadmap for Gene Editing Market; 3.7 Value Chain Analysis; 3.7.1 List of Key Manufacturers; 3.7.2 List of Customers; 3.7.3 Level of Integration; 3.8 Cost Structure Analysis; 3.8.1 Price Trend of Key Raw Materials; 3.8.2 Raw Material Suppliers; 3.8.3 Proportion of Manufacturing Cost Structure; 3.8.3.1 Raw Material; 3.8.3.2 Labor Cost; 3.8.3.3 Manufacturing Expense; 3.9 Regulatory Compliance; 3.10 Competitive Landscape, 2024; 3.10.1 Player Positioning Analysis; 3.10.2 Key Strategies Adopted By Leading Players
CHAPTER 4 Manufacturing Plant Analysis: 4.1 Manufacturing Plant Location and Establish Date of Major Manufacturers in 2024; 4.2 R&D Status of Major Manufacturers in 2024
CHAPTER 5 Gene Editing Market By Technology: 5.1 Introduction; 5.2 Gene Editing Revenue By Technology; 5.2.1 Gene Editing Revenue (USD Billion) and Forecast, By Technology, 2021-2033; 5.2.2 CRISPR; 5.2.2.1 CRISPR Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.3 TALEN; 5.2.3.1 TALEN Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.4 ZFN; 5.2.4.1 ZFN Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 5.2.5 Other Technologies; 5.2.5.1 Other Technologies Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 6 Gene Editing Market By Product & Services: 6.1 Introduction; 6.2 Gene Editing Revenue By Product & Services; 6.2.1 Gene Editing Revenue (USD Billion) and Forecast, By Product & Services, 2021-2033; 6.2.2 Reagents & Consumables; 6.2.2.1 Reagents & Consumables Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.3 Software & Systems; 6.2.3.1 Software & Systems Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 6.2.4 Services; 6.2.4.1 Services Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 7 Gene Editing Market By Application: 7.1 Introduction; 7.2 Gene Editing Revenue By Application; 7.2.1 Gene Editing Revenue (USD Billion) and Forecast, By Application, 2021-2033; 7.2.2 Cell Line Editing; 7.2.2.1 Cell Line Editing Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 7.2.3 Animal Genome Editing; 7.2.3.1 Animal Genome Editing Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 7.2.4 Plant Genome Editing; 7.2.4.1 Plant Genome Editing Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 7.2.5 Other; 7.2.5.1 Other Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 8 Gene Editing Market By End-user: 8.1 Introduction; 8.2 Gene Editing Revenue By End-user; 8.2.1 Gene Editing Revenue (USD Billion) and Forecast, By End-user, 2021-2033; 8.2.2 Pharmaceutical & Biotechnology Companies; 8.2.2.1 Pharmaceutical & Biotechnology Companies Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 8.2.3 Academics And Government Research Institutes; 8.2.3.1 Academics And Government Research Institutes Market Revenue (USD Billion) and Growth Rate (%), 2021-2033; 8.2.4 Clinical Research Organizations (CRO); 8.2.4.1 Clinical Research Organizations (CRO) Market Revenue (USD Billion) and Growth Rate (%), 2021-2033
CHAPTER 9 North America Gene Editing Market By Country: 9.1 North America Gene Editing Market Overview; 9.2 U.S.; 9.2.1 U.S. Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 9.2.2 U.S. Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 9.2.3 U.S. Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 9.2.4 U.S. Gene Editing Revenue (USD Billion) and Forecast By End-Use, 2021-2033; 9.3 Canada; 9.3.1 Canada Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 9.3.2 Canada Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 9.3.3 Canada Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 9.3.4 Canada Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 9.4 North America PEST Analysis
CHAPTER 10 Europe Gene Editing Market By Country: 10.1 Europe Gene Editing Market Overview; 10.2 U.K.; 10.2.1 U.K. Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 10.2.2 U.K. Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 10.2.3 U.K. Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 10.2.4 U.K. Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.3 Germany; 10.3.1 Germany Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 10.3.2 Germany Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 10.3.3 Germany Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 10.3.4 Germany Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.4 France; 10.4.1 France Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 10.4.2 France Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 10.4.3 France Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 10.4.4 France Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.5 Spain; 10.5.1 Spain Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 10.5.2 Spain Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 10.5.3 Spain Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 10.5.4 Spain Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.6 Rest of Europe; 10.6.1 Rest of Europe Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 10.6.2 Rest of Europe Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 10.6.3 Rest of Europe Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 10.6.4 Rest of Europe Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 10.7 Europe PEST Analysis
CHAPTER 11 Asia Pacific Gene Editing Market By Country: 11.1 Asia Pacific Gene Editing Market Overview; 11.2 China; 11.2.1 China Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 11.2.2 China Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 11.2.3 China Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 11.2.4 China Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.3 Japan; 11.3.1 Japan Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 11.3.2 Japan Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 11.3.3 Japan Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 11.3.4 Japan Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.4 India; 11.4.1 India Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 11.4.2 India Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 11.4.3 India Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 11.4.4 India Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.5 Australia; 11.5.1 Australia Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 11.5.2 Australia Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 11.5.3 Australia Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 11.5.4 Australia Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.6 South Korea; 11.6.1 South Korea Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 11.6.2 South Korea Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 11.6.3 South Korea Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 11.6.4 South Korea Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.7 Rest of Asia-Pacific; 11.7.1 Rest of Asia-Pacific Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 11.7.2 Rest of Asia-Pacific Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 11.7.3 Rest of Asia-Pacific Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 11.7.4 Rest of Asia-Pacific Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 11.8 Asia Pacific PEST Analysis
CHAPTER 12 Latin America Gene Editing Market By Country: 12.1 Latin America Gene Editing Market Overview; 12.2 Brazil; 12.2.1 Brazil Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 12.2.2 Brazil Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 12.2.3 Brazil Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 12.2.4 Brazil Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 12.3 Mexico; 12.3.1 Mexico Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 12.3.2 Mexico Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 12.3.3 Mexico Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 12.3.4 Mexico Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 12.4 Rest of Latin America; 12.4.1 Rest of Latin America Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 12.4.2 Rest of Latin America Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 12.4.3 Rest of Latin America Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 12.4.4 Rest of Latin America Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 12.5 Latin America PEST Analysis
CHAPTER 13 Middle East & Africa Gene Editing Market By Country: 13.1 Middle East & Africa Gene Editing Market Overview; 13.2 GCC; 13.2.1 GCC Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 13.2.2 GCC Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 13.2.3 Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 13.2.4 Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 13.3 South Africa; 13.3.1 South Africa Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 13.3.2 South Africa Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 13.3.3 South Africa Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 13.3.4 South Africa Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 13.4 Rest of Middle East & Africa; 13.4.1 Rest of Middle East & Africa Gene Editing Revenue (USD Billion) and Forecast By Technology, 2021-2033; 13.4.2 Rest of Middle East & Africa Gene Editing Revenue (USD Billion) and Forecast By Product & Services, 2021-2033; 13.4.3. Rest of Middle East & Africa Gene Editing Revenue (USD Billion) and Forecast By Application, 2021-2033; 13.4.4 Rest of Middle East & Africa Gene Editing Revenue (USD Billion) and Forecast By End Use, 2021-2033; 13.5 Middle East & Africa PEST Analysis
CHAPTER 14 Player Analysis Of Gene Editing Market: 14.1 Gene Editing Market Company Share Analysis; 14.2 Competition Matrix; 14.2.1 Competitive Benchmarking of key players by price, presence, market share, and R&D investment; 14.2.2 New Product Launches and Product Enhancements; 14.2.3 Mergers And Acquisition In Global Gene Editing Market; 14.2.4 Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15 Company Profile: 15.1 Sangamo Biosciences; 15.1.1 Company Snapshot; 15.1.2 Business Overview; 15.1.3 Financial Overview; 15.1.3.1 Revenue (USD Billion), 2024; 15.1.3.2 Sangamo Biosciences 2024 Gene Editing Business Regional Distribution; 15.1.4 Product /Service and Specification; 15.1.5 Recent Developments & Business Strategy; 15.2 Addgene; 15.3 Thermo Fisher Scientific; 15.4 Horizon Discovery Group plc; 15.5 Allele Biotech; 15.6 Bio-Rad; 15.7 Caribou Biosciences, Inc.; 15.8 Precision Biosciences; 15.9 CRISPR Therapeutics; 15.10 GE Healthcare; 15.11 GeneCopoeia, Inc; 15.12 Integrated DNA Technologies; 15.13 GenScript Corporation; 15.14 OriGene Technologies